Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (251-260 of 350) with videos related to

Pageof 35
Sort By:
Neuropathology and Applied Neurobiology|June 6, 2021
Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel-Lindau disease-related tumoursLeonille Schweizer, Felix Thierfelder, Christian Thomas, et al.
Journal of Neuro-Oncology|May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cellsGintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Brain Pathology (Zurich, Switzerland)|November 18, 2014
Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profilesChristian Koelsche, Volker Hovestadt, David T W Jones, et al.
Acta Neuropathologica|June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entitiesDavid E Reuss, Annekathrin Kratz, Felix Sahm, et al.
Acta Neuropathologica|May 2, 2015
Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gainChristoph Geisenberger, Andreas Mock, Rolf Warta, et al.
Acta Neuropathologica|August 11, 2020
Infratentorial IDH-mutant astrocytoma is a distinct subtypeRouzbeh Banan, Damian Stichel, Anja Bleck, et al.
Acta Neuropathologica|January 27, 2017
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivoStefan Pusch, Sonja Krausert, Viktoria Fischer, et al.
Neuro-Oncology|January 31, 2016
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsChristian Thomas, Martin Sill, Vincent Ruland, et al.
Acta Neuropathologica|July 4, 2018
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experienceDavid Capper, Damian Stichel, Felix Sahm, et al.
Neuropathology and Applied Neurobiology|October 16, 2024
DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centresMihaela Chirica, Philipp Jurmeister, Daniel Teichmann, et al.
Pageof 35

Showing results (251-260 of 350) with videos related to

Sort By:
Pageof 35
Neuropathology and Applied Neurobiology|June 6, 2021
Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel-Lindau disease-related tumoursLeonille Schweizer, Felix Thierfelder, Christian Thomas, et al.
Journal of Neuro-Oncology|May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cellsGintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Brain Pathology (Zurich, Switzerland)|November 18, 2014
Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profilesChristian Koelsche, Volker Hovestadt, David T W Jones, et al.
Acta Neuropathologica|June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entitiesDavid E Reuss, Annekathrin Kratz, Felix Sahm, et al.
Acta Neuropathologica|May 2, 2015
Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gainChristoph Geisenberger, Andreas Mock, Rolf Warta, et al.
Acta Neuropathologica|August 11, 2020
Infratentorial IDH-mutant astrocytoma is a distinct subtypeRouzbeh Banan, Damian Stichel, Anja Bleck, et al.
Acta Neuropathologica|January 27, 2017
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivoStefan Pusch, Sonja Krausert, Viktoria Fischer, et al.
Neuro-Oncology|January 31, 2016
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsChristian Thomas, Martin Sill, Vincent Ruland, et al.
Acta Neuropathologica|July 4, 2018
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experienceDavid Capper, Damian Stichel, Felix Sahm, et al.
Neuropathology and Applied Neurobiology|October 16, 2024
DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centresMihaela Chirica, Philipp Jurmeister, Daniel Teichmann, et al.
Pageof 35